Autologous Epidermal Cultures and Narrow-Band Ultraviolet B in the Surgical Treatment of Vitiligo
| Autor: | A. Andreassi, Lucio Andreassi, Massimiliano Risulo, Francesca Ierardi, Elisa Pianigiani, Paolo Taddeucci |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Ultraviolet Rays Cell Culture Techniques Vitiligo Skin Pigmentation Dermatology Transplantation Autologous chemistry.chemical_compound Hyaluronic acid medicine Humans Surgical treatment Cells Cultured Pigmentation disorder integumentary system business.industry Social impact Ultraviolet b Skin Transplantation General Medicine Middle Aged medicine.disease Autologous grafting Surgery Narrow band Treatment Outcome chemistry Melanocytes Female business |
| Zdroj: | Dermatologic Surgery. 31:155-159 |
| ISSN: | 1076-0512 |
| DOI: | 10.1111/j.1524-4725.2005.31036 |
| Popis: | Background Vitiligo is an acquired skin disorder with a great social impact. It can be successfully treated with autologous epidermal grafting. Objective To evaluate the possibility of treating vitiligo by autologous grafting of epidermal cells and narrow-band ultraviolet B (UVB). Methods Autologous epidermal cultures were prepared starting from small biopsies of normally pigmented skin. Cells were cultured on hyaluronic acid membranes using medium supplemented with patient's serum. Cell cultures were grafted onto laser-abraded depigmented areas. Patients underwent narrow-band UVB therapy 3 weeks after grafting. Results Repigmentation of the grafted areas started 1 month after transplant and continued until 4 months after grafting. All patients were evaluated 3, 6, 12, and 18 months after grafting. At the 18-month follow-up, repigmentation was observed in 75% of patients with focal and segmental vitiligo and in 30% of patients with generalized vitiligo. Conclusions This therapy can be considered for the treatment of stable vitiligo (especially focal and segmental) resistant to standard therapies. Their results are encouraging from the clinical and esthetic point of view, although the treatment is costly and highly specialized. ELISA PIANIGIANI, MD, MASSIMILIANO RISULO, MD, ANDREA ANDREASSI, MD, PAOLO TADDEUCCI, MD, FRANCESCA IERARDI, MD, AND LUCIO ANDREASSI, MD, HAVE INDICATED NO SIGNIFICANT INTEREST WITH COMMERCIAL SUPPORTERS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text